Bloomberg the Company

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Tokyo
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

CanBas Co Ltd

+ Add to Watchlist


1,718.0 JPY 32.0 1.83%

As of 01:00:00 ET on 01/30/2015.

Company Profile for CanBas Co Ltd (4575)

CanBas Company Ltd. is a biopharmaceutical company that develops anti-cancer drugs with fewer side effects. The Company's core technologies include drugs that target the G2 checkpoint and a screening system to find selective abrogators of the G2 checkpoint.

Contact Information

CanBas Co Ltd

2-2-1 Otemachi
Phone: 81-55-954-3666
Fax: 81-55-954-3668

Key Executives for CanBas Co Ltd (4575)

Takumi KawabePresidentMakoto KatozumiDirector/CFO
Kazuyoshi SakamotoDirector

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil